chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a pharmacist referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were not reported. On 14-AUG-2016, the patient was vaccinated with improperly stored PNEUMOVAX 23 (lot # L049744, expiration date 12-OCT-2017, dose and route were not reported). No adverse reactions were reported. This is one of the two reports received from the same reporter. Additional information has been requested.
LOSS OF BALANCE (DIZZINESS) CHRONIC HEADACHE (LEFT FRONTAL LOBE) CONSTIPATION WEAKNESS EXTREME SUGAR FLUCTUATIONS  CONTACTS RN  HEALTH DEPARTMENT
Patient got vaccinated at 10:30am, 5 minutes later patient reported not feeling well and lightheaded. Patient was laid down and elevated feet. VS:(sitting) @10:36am BP 138/105 HR 50 SpO2 97%. VS (supine) @10:37am BP 90/52 HR 59 spo2 96%. Patient was given orange juice, no signs of aspiration noted. At 10:45am patient reported feeling less lightheaded. EMS called @ 10:46am for further management. VS @ 10:47am BP 108/54 HR 74 spo2 98%. @10:58am EMS arrived, assessed patient, VS BP 113/75 HR 71 spo2 99%. Patient sitting up. @11:00 am, patient was discharged home, refused any further care or hospital visit.
pt recvd vax & devel pain @inj site. Pain only when she lifted arm w/elbow bent. 03/31/97 still exp pain several times per day.
Numbness in arm of injection site, happened with the 1st dose, as well. CG received 1st dose and 2nd dose in different arms. Numbness was limited and resolved shortly without intervention
Information has been received from a pharmacist referring to an unspecified adult patient of unknown age and gender. The patient's pertinent medical history, drug reaction/allergies and concomitant medication were not provided. On 22-SEP-2016, the adult patient was vaccinated with a pediatric dose of VAQTA (0.5 ml, once; route, lot # and expiration date were unknown). No adverse effects were reported. Additional information has been requested.
Itching, extremely hot sore arm, fever, chills extreme headache, muscle aches.
Pt vaccinated with DTP developed high fever 105, irritability for less than 24 hrs.
Initial report received from a consumer on 08 September 2010. A female patient (age not provided) received on 20 December 2009 an injection (route not provided) to an arm of H1N1, lot number UP044AA. The patient reported that she still has welts on the arm at location of injection. No other information provided. The outcome was not reported. Documents held by sender: None.
DILATED PUPILS; EVERY SIDE EFFECT LISTED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced dilated pupils, and every side effect listed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dilated pupils and every side effect listed was not reported. This report was non-serious.
The pt experienced a fever up to 103.8 for two days then it dropped to 100 - 101 for 2 days. The fever began the same day as vax. Throat was red, glands were swollen. No rash was noted. MD states he cannot rule out that the MMR vax as cause however it could also be viral.
This spontaneous report as received from a healthcare professional refers to a patient of unknown age and gender. The patient's concurrent condition and medical history were not reported. On an unknown date the patient was vaccinated with PNEUMOVAX 23 [Lot# 011531, Expiry date: 07-JAN-2017] (strength, dose and route of administration were not reported) which was improperly stored at a temperature of 51 degree Fahrenheit for total 30 hours. No adverse events were reported. Additional information has been requested.
Patient was given the 2nd Moderna vaccine 8 days early before the recommended time between the 1st and 2nd dose.   Patient has been notified of the vaccine administration error.
pt is partially paralyzed, not back to work yet; had GBS; pt explained that office is a pediatric office provided to pt because works upstairs; pt has no medical hx, no other info;
Information has been rec'd from a physician concerning a pt who was vaccinated with varicella virus vaccine live (site unknown). Subsequently the pt developed mild varicella. The pt's sister experienced mild varicella (WAES01020208) after being vaccinated also. Additional information is not expected.
This spontaneous report was received from a medical assistant, referring to a  multiple unspecified patients of unknown ages and genders. The patients' pertinent medical history, concurrent conditions and concomitant medications were not provided. On an unknown date, the patients were vaccinated with and incorrect stored dose of VAQTA (strength, route, lot # and expiration date  were not reported) for prophylaxis, however no adverse effects reported. It was reported that the vaccines were exposed to temperature of 47 Farenheit grades range for a time frame of 5 minutes. The temperature excursion was recorded by a data logger and no previous excursions were reported for the vaccines. There was no product quality complaint involved. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1709USA007303: US-009507513-1709USA007306: US-009507513-1706USA002054: US-009507513-1709USA004085:
Developed anterior uveitis after months of no flare-ups within 7 Days of receiving my second Pfizer covid-19 vaccination.
too late for the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (too late for the second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided.     On 09-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (too late for the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (too late for the second dose) had resolved.            No concomitant medication reported. No treatment information was provided.
lt side face swelling from face to hands, fingers...has not subsided, 2 Tylenol 1 Benadryl 9:15pm last night 6/8/21, nausea
Egg allergic infant with urticaria and angioedema of eyelids 2 hours after receiving infanrix, influenza vaccine and PREVNAR.
Information has been received from a consumer his 5 year old son with no allergies or medical history who on 7/6/04 was vaccinated SC in the right arm with a first dose of varicella virus vaccine live (lot # 641987/1018N). Concomitant vaccination on the same day included a second SC dose in the right arm of MMR (lot # 646738/0819N), a fifth IM dose in the left arm of diphtheria toxoid (+) pertussis acellular vaccine (+) tetanus toxoid (lot # C1354BA), and a fourth SC dose in the left arm of poliovirus vaccine inactivated (lot # W1619). The reporter indicated that the patient received varicella virus vaccine live that was exposed to temperatures above recommended. He also reported that on 7/7/04 the patient was experiencing sleeplessness and appeared edgier than usual. No medical attention was sought and no treatment was required. No diagnostic laboratory tests were performed. A product quality complaint was not involved. Additional information was received from a registered nurse who indicated that the varicella virus vaccine live had been previously exposed to higher than recommended temperatures. The vaccine received on revised use by date and was past the revised use by date, but not past the expiration date. Follow up information was received from the registered nurse who indicated that she was not aware of any adverse event. She notified the patient's father that the vaccine was administered past the use by date and needed to be repeated after 8/6/04. The father was concerned about this affect on his child. The vaccine had an earlier use by date than assigned expiration date. No further information is expected.
I received the vaccine at 11:30am. About a half hour after receiving the vaccine, I felt dizziness and very slight chest tightness. I took benadryl, and was relieved of these symptoms. Then, around 9pm that night, I developed a fever. The highest temperature I recorded was 101.9. I took Ibuprofen around 11pm, and was afebrile by 3am. I have not had any fevers since, and I did have to call off work New Year's day. I have had an intermittent, mild headache since receiving the vaccine as well,  but overall I feel fine.
bruising on his abdomen on day 7-10 after administration/bruises on his belly; large bump/swollen lymphnodes behind right ear; Pain in whole body; spot on eyelid; This is a spontaneous report from a contactable consumer (patient) via medical information team.  A 45-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6199) via an unspecified route of administration in right arm on 10Mar2021 (at the age of 45-years-old) as dose 1, single for COVID-19 immunization. The patient medical history included ongoing high risk High blood pressure (Diagnosed 27 years ago), Overweight (Diagnosed 25 years ago), and Asthma (Diagnosed as a child). The patients concomitant medications were not reported. Reporter stated that he received the first dose of the Covid vaccine on 10Mar2021 and was scheduled to receive the second dose 31Mar2021. Reporter stated that he was having reactions to the vaccine, on 17Mar2021 specifically bruising on his abdomen on day 7-10 after administration. Patient consulted with his health care professional, but he was not sure if he should get the second dose. Reporter queried for if there was any information regarding the side effect he was experiencing. Reporter stated that he wanted to report side effects for first shot. Stated that he had to have the second one on the 31st. Stated that after 10 days after that he had bruises on his belly. Wanted to know if he should get the second shot. Stated that he went to the doctor Monday and he did blood work to see coagulation and all related. Stated that everything came back on the normal range. On unspecified date Mar2021 third day developed spot on eyelid, large bump/swollen lymph nodes behind right ear, pain in whole body. On tenth day bruises on stomach after sleeping. Health care professional ran coagulation test that came back normal, reporter still concerned. Patient had not received any treatment for the events bruising on his abdomen on day 7-10 after administration/bruises on his belly. Outcome of events bruising on his abdomen on day 7-10 after administration/bruises on his belly was recovering and all other events was unknown.  No follow-up attempts are possible. No further information is expected
Approximately 10 minutes after administration of injection, pt felt extremely hot and some lightheadedness and nausea. VS 158/89 pulse 95 temp 98.1 F.  Pt sat down and was given some water. Pt recovered from all symptoms in under 15 mins. Area surrounding IM site remains warm to touch, no hardening, no hives.
Pt. complained of a rash which appeared on both arms from the elbows to the shoulder. Denies itching or pain. Rash duration of 2 hours and occurred 1 hour following immunization. Pt did not see doctor no tx was given.
Broke out in rash on the 16th, called for a teladoc appointment.    Just let it play out as it went away after a few days.
24 hrs after injection of Varivax developed moderate and local reaction-erythema and induration 5 1/2 cm x 9 cm-cool compresses off and on and watch closely per physician
pneumococcal vaccine and pneumovax vaccine, date of vaccination: 2016; This spontaneous report was received from a 68-year-old female patient, concerning to herself. The patient's medical history, previous drug reactions or allergies and concomitant medications were not reported.  On an unknown date in 2016, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (reported as "Pneumococcal") and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) for prophylaxis (strength, dose, route of administration, anatomical location, lot # and expiration date were not provided) (inappropriate schedule of product administration).; Sender's Comments:  US-009507513-2004USA000752:
Patient received first dose of Pfizer Covid-19 Vaccine. Patient has a history of allergies to shrimp. Patient was directed to observation for a 30 minute waiting period. Patient stated that she was feeling constriction in her throat, SOB, chest tightness. Patient presented as anxious and having trouble breathing. Patient was assessed by RN, vitals were taken and recorded upon further exam, patient presented with more symptoms of anaphylaxis. ED proceed out was called. RN administered epinephrine to the L lateral thigh. ED team arrived and patient was evaluated and patient was taken to ED with ED team. In ED patient received diphenhydramine oral tablets and was observed for few hours. No further complaint was reported. Patient was discharged home afterwards.
Extreme elevation of  blood pressure for over two weeks . Continuous constant tinnitus. Losartan 25 mg once a day for BP, currently  symptom has improved but BP is not back to normal. 60 mg prednisone taper over 7 days for tinnitus: no significant improvement  of symptom currently
Arm swollen and sensitive to touch.  Within two hours developed a very rapid heart beat (160 resting).  Pt took an additional Inderal tablet (10 mg), to control rapid beat. Fever and muscle aches for one day, arm sore during this time.
Patient was given a PENTACEL and a Hib Prp-omp in the left leg so he received a double dose of Hib.
Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 33-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included Gestational diabetes (2019), Alcohol use (1 to 2 drinks per week) and Delivery (Pregnancy complication-Patient had gestational diabetes; Pregnancy outcome: Live, full-term birth) on 24-May-2019. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 26-Sep-2020 and the estimated date of delivery was 26-Jun-2021. On 09-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifteenth week of the pregnancy.  On 09-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Oct-2020, Pregnancy test: positive (Positive) Positive. On 25-Oct-2020, SARS-CoV-2 test: positive (Positive) Positive. On 13-Nov-2020, Ultrasound foetal: normal (normal) Pregnancy Confirmed.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided by the reporter. Estimated date of conception 01 oct 2020.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow-up received on 14-jun-2021 contains reporter's E-mail id.; Sender's Comments: .
child was administered with an expired Daptacel; Initial information received on 15-May-2019 regarding an unsolicited valid non-serious case received from a nurse.   This case involves a 12 months old female patient who was vaccinated with first dose expired DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (lot C5190AA, expiry date- 24-Apr-2019) vaccine on 10-May-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HIB VACCINE CONJ (TET TOX) (ACTHIB) which was received during the same visit.  It is an actual medication error due to expired vaccine used.  It was not reported if the patient experienced any adverse event following vaccination.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive  and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
chills overnight, low fever, up to 100. Normal is 97.6. Body aches, especially in lymph nodes,  side of hip, side of throat
Injection site pain; This is a spontaneous report from a contactable consumer. A 29-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 10:15 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included unspecified birth control medication from an unknown date for an unknown indication and unknown if ongoing. It was unknown if the patient was pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021, the patient experienced injection site pain. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event injection site pain was resolving at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
mom stated high fever & pt cried a lot;mom gave APAP & tepid baths-finally calmed down late in evening (mom unsure if temp 100.5 or 105);
Severe redness and Minor swelling at the vaccine site that will not go away. At the time of swelling (05/18/2021) the site became itchy
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. Medical history was not reported. The nurse informed that on 02-JUN-2014 the patient was vaccinated with M-M-R II (strength, dosage and route were not reported) lot number: J006138, expiration date: 17-APR-2015. That may had been improperly stored since February 2014. The thermometer battery ran out in February 2014, so the refrigerator temperature was not able to be confirmed to be within recommended storage temperature since then. The highest temperature the M-M-R II could had been exposed was 70F. Also stated that was no way to determine what the exact temperature was at any given time after 01-FEB-2014 since the battery in the thermometer stopped working. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a physician concerning an 18 year old female with "unremarkable" medical history who in April 2007, was vaccinated with a first dose of Gardasil. Subsequently, the patient experienced welts, itching all over body, and nausea. The patient sought unspecified medical attention. The patient recovered from welts, itching all over body and nausea approximately 3 days after initial injection. The physician did plan on administering further doses of Gardasil to this patient. Additional information has been requested.
Slight fever and sore arm. Went away not long after and fine now!  Took some Tylenol.
4-5cm circumferential erythema, warm, painful to touch at vaccine site. Moderate drainage. Treat with Levaquin 750mg PO daily for 5 days.
Pt received Pfizer Covid-19 vaccine at 1530. At 1540, reported that her throat "felt itchy, like after a bee sting". Pt reports that after a bee sting she typically takes two benedryl and has not ever used epinephrine. Pt was given 50 mg benedryl po. She waited with her husband in the vaccine waiting area for 15 more minutes and reported she was feeling fine and left. Declined needing to go to ER.
02/25/2000 Pt sought treatment for left arm pain which had increased since the most recent vax in series. 03/22 Pt sought medical treatment and physician ruled out carpal tunnel syndrome, left ulnar neuropathy, and left brachial plexopathy in muscles. 04/03 Pt received a 13 day leave from work due to dx of anxiety and depression. 04/05 Pt consulted with ophthalmologist for adult strabismus in right eye which had also become more erratic post his 4th vax. His dx was intermittent exotropia, convergence insufficiency, and myopic astigmatism. Noted also that his medical history was significant for left arm pain and numbness of unknown etiology. Pt is also experiencing neck pain.
Approximately 17 hrs after taking 1st capsule of vaccine, developed fever, body aches, abdominal pain and diarrhea. Persisted 5-6 day. Resolved with time and Septra DS po bid x 10 days.
About 2.5-3" round, red rash at injection site. Warm to touch. Not raised.
Day after vaccination, student had fever 101, body aches, headache, nausea w/ syncopal episode. Student was driven to the student health center where she was evaluated. Improved with oral fluids and Tylenol. Discharged home.
Itching and hives on my neck, right buttock, hands and arms. After three days I had to go to an Urgent Care where they prescribed me Methylprednisolone tablets, USP 4 mg per tablet, 21 tablets. I finished them however once in a while I still have itching and hives.
A blood clot in each of my renal arteries, as a result I am now taking the following medications: Warfarin 2.5 mg, Hydrochloroth-Iazide 12.5 mg, and Amlodipine Besylate 5mg.  It was determined that blood clots were not caused by heart issues or any type of blood disorder.
After the vaccine patient experience difficult of breathing, said that he cough out a lot of black tar. After a week, the phlegm was clear but patient began experience swollen face and chest. Patient went to see an MD and was advise to rest. On Sept 1st 2017 patient had edema from trunk, scrotum, legs; patient went to urgent care and was hospitalized since.
Low grade fever, 99.5.  Patient took 2 Tylenol and after an hour his fever was gone.
pt recvd vax & exp an adverse event; pt had a severe inject site react, redness, & pain lasting 3 days; treated w/anti-pyretics & hot soaks to site;